0000873303EX-FILING FEESfalse 0000873303 2024-08-07 2024-08-07 0000873303 1 2024-08-07 2024-08-07 iso4217:USD xbrli:pure xbrli:shares
Exhibit 107
Calculation of filing Fee Tables
Form
S-8
(Form Type)
Sarepta Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1—Newly Registered Securities
 
               
Security
Type
 
Security
Class
Title
 
Fee
Calculation
Rule
 
Amount
Registered (1)
 
Proposed
Maximum
Offering
Price
Per Unit
 
Proposed
Maximum
Aggregate
Offering
Price
 
Fee
Rate
 
Amount of
Registration
Fee
               
Equity   Common Stock, par value $0.0001 per share   Other—Rule 457(c) and Rule 457(h)   500,000 (2)     $139.59 (3)     $69,795,000.00   0.00014760    $10,301.75
         
Total Offering Amounts     $69,795,000.00     $10,301.75
         
Total Fee Offsets        
         
Net Fees Due               $10,301.75
 
(1)
Pursuant to Rule 416(a) under the Securities Act of 1933, as amended, this Registration Statement on Form
S-8
shall also cover shares of the Registrant’s common stock that become issuable under the Registrant’s 2024 Employment Commencement Incentive Plan, as amended (the “Plan”), to prevent dilution as a result of any stock dividend, stock split, recapitalization or similar transaction.
(2)
Represents 500,000 shares of common stock reserved for future issuance under the Plan.
(3)
Estimated solely for the purpose of determining the registration fee pursuant to Rule 457(c) and 457(h) under the Securities Act, the “proposed maximum offering price per share” is calculated based on the average of the high and low prices for the Registrant’s common stock as reported on the Nasdaq Global Select Market on August 5, 2024.